Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction

The loss of strength in combination with constant fatigue is a burden on cancer patients undergoing chemotherapy. Doxorubicin, a standard chemotherapy drug used in the clinic, causes skeletal muscle dysfunction and increases mitochondrial H(2)O(2). We hypothesized that the combined effect of cancer...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Physiol Endocrinol Metab
Hlavní autoři: Gilliam, Laura A. A., Lark, Daniel S., Reese, Lauren R., Torres, Maria J., Ryan, Terence E., Lin, Chien-Te, Cathey, Brook L., Neufer, P. Darrell
Médium: Artigo
Jazyk:Inglês
Vydáno: American Physiological Society 2016
Témata:
Call for Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5005971/
https://ncbi.nlm.nih.gov/pubmed/27329802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00540.2015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky